|
|
|
|
Keryx Biopharmaceuticals Announces Completion of Patient Enrollment in KRX-0401 (Perifosine)
Phase 3 Refractory Advanced Colorectal Cancer Study ... More
Keryx Biopharmaceuticals to Present at Jefferies 2011 Global Healthcare Conference ... More
Phase 3 Refractory Advanced Colorectal Cancer Study ... More
Keryx Biopharmaceuticals to Present at Jefferies 2011 Global Healthcare Conference ... More
Keryx maintains this website as a service to the Internet community. Access to and use of information presented on the Keryx website is subject to the terms and conditions described in "Use of the Keryx website".
Copyright © 2011 by Keryx Biopharmaceuticals, Inc.
Copyright © 2011 by Keryx Biopharmaceuticals, Inc.